Form 4: Merck SVP Fin. Global Controller, Dalton E. Smart III, Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Dalton E. Smart III, SVP Fin. Global Controller at Merck & Co., Inc., exercised stock options and sold shares on April 25, 2025.
Summary
- On April 25, 2025, Dalton E. Smart III, SVP Fin. Global Controller at Merck & Co., Inc., exercised stock options to acquire 5,000 shares of common stock at a price of $58.08 per share.
- On the same day, Smart sold 4,262 shares of common stock at a price of $82.76 per share.
- Following these transactions, Smart directly owns 7,777.802 shares of Merck common stock.
- Smart also holds options for 0 shares of Merck common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of insider trading activity, with no inherent positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies like Merck. These filings are monitored by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock option exercises and sales are a common practice across the pharmaceutical industry.
- Companies like Pfizer (PFE) and Johnson & Johnson (JNJ) also have executives who regularly report similar transactions via Form 4 filings.
- The reported transactions are typical in terms of the size and frequency for an executive at Smart's level.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely negligible given the overall size of the company.
Key Dates
| Date | Description |
|---|---|
| 05/01/2016 | Option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. |
| 04/25/2025 | Date of transaction: exercise of stock options and sale of shares. |
| 04/30/2025 | Expiration date of the stock options. |
| 04/29/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Merck & Co., MRK, Dalton E. Smart III, Stock Options, Insider Trading, Beneficial Ownership, SVP Fin. Global Controller
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.